KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
32 hedge funds and large institutions have $111M invested in Kalaris Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 29 reducing their positions, and 23 closing their positions.
Holders
32
Holders Change
-21
Holders Change %
-39.62%
% of All Funds
0.43%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
1
Reduced
29
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SB
1
Samsara BioCapital
Palo Alto,
California
|
$91.9M |
2 |
CCM
2
Coldstream Capital Management
Bellevue,
Washington
|
$1.67K |